10.3389/fphys.2018.01622 Summary Keywords dipeptidyl peptidase-4, glucagon-like peptide-1, incretin, peptide degradation, therapy, type 2 diabetes Citation Deacon CF (2019) Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
Its important to note that Hims business model isnt isolated
As a result, the researchers said this finding suggests there are multiple ways the drug benefits the heart, rather than its protective effect on cardiovascular health being due solely to weight loss, which may include supporting the health of the lining of blood vessels, reduced inflammation, improved blood pressure control and lower lipid levels
Semaglutide GLP-1 and Tirzepatide are both effective weight loss treatments, but they work in slightly different ways